 Raymond Estacio
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 17 | 2023 | 1726 | 1.800 |
Why?
| | Community Health Services | 3 | 2017 | 212 | 0.920 |
Why?
| | Albuminuria | 6 | 2023 | 164 | 0.840 |
Why?
| | Diabetes Mellitus, Type 2 | 14 | 2012 | 2087 | 0.840 |
Why?
| | Health Promotion | 4 | 2023 | 675 | 0.750 |
Why?
| | Hypertension | 9 | 2016 | 1052 | 0.700 |
Why?
| | Case Management | 2 | 2012 | 61 | 0.680 |
Why?
| | Antihypertensive Agents | 6 | 2016 | 428 | 0.560 |
Why?
| | Program Evaluation | 3 | 2017 | 820 | 0.550 |
Why?
| | Primary Health Care | 4 | 2017 | 1502 | 0.550 |
Why?
| | Lipoproteins, LDL | 2 | 2017 | 127 | 0.510 |
Why?
| | Risk Reduction Behavior | 2 | 2017 | 200 | 0.490 |
Why?
| | Text Messaging | 2 | 2015 | 152 | 0.490 |
Why?
| | Diabetes Mellitus | 3 | 2012 | 898 | 0.460 |
Why?
| | Community Health Workers | 1 | 2012 | 45 | 0.400 |
Why?
| | Coronary Disease | 2 | 2012 | 348 | 0.400 |
Why?
| | Nursing Care | 1 | 2012 | 30 | 0.380 |
Why?
| | Patient Admission | 1 | 2012 | 175 | 0.350 |
Why?
| | Colorado | 12 | 2015 | 4090 | 0.340 |
Why?
| | Renin | 1 | 2009 | 31 | 0.320 |
Why?
| | Patient Acceptance of Health Care | 1 | 2015 | 675 | 0.320 |
Why?
| | Renin-Angiotensin System | 1 | 2009 | 72 | 0.310 |
Why?
| | Phosphorus | 1 | 2009 | 81 | 0.310 |
Why?
| | Nursing Diagnosis | 1 | 2008 | 16 | 0.300 |
Why?
| | Heart Rate | 2 | 2011 | 710 | 0.300 |
Why?
| | Community-Institutional Relations | 1 | 2008 | 89 | 0.290 |
Why?
| | Cardiac Output, Low | 1 | 2008 | 64 | 0.290 |
Why?
| | Drug Prescriptions | 1 | 2009 | 237 | 0.280 |
Why?
| | Risk Factors | 11 | 2023 | 8614 | 0.280 |
Why?
| | Blood Pressure | 6 | 2016 | 1531 | 0.280 |
Why?
| | Middle Aged | 27 | 2017 | 26605 | 0.280 |
Why?
| | Tetrazoles | 1 | 2006 | 32 | 0.270 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 29 | 0.270 |
Why?
| | Valine | 1 | 2006 | 72 | 0.270 |
Why?
| | Aged | 18 | 2017 | 18969 | 0.260 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2016 | 1204 | 0.260 |
Why?
| | Blood Pressure Determination | 2 | 2017 | 122 | 0.260 |
Why?
| | Cohort Studies | 10 | 2012 | 4883 | 0.240 |
Why?
| | Medication Adherence | 1 | 2009 | 531 | 0.240 |
Why?
| | Lipids | 1 | 2008 | 564 | 0.240 |
Why?
| | Diabetic Nephropathies | 2 | 2006 | 234 | 0.230 |
Why?
| | Telemedicine | 1 | 2012 | 662 | 0.220 |
Why?
| | Adult | 16 | 2022 | 30375 | 0.210 |
Why?
| | Humans | 38 | 2023 | 114043 | 0.200 |
Why?
| | Follow-Up Studies | 9 | 2012 | 4392 | 0.200 |
Why?
| | Medically Underserved Area | 2 | 2015 | 80 | 0.190 |
Why?
| | Proportional Hazards Models | 5 | 2012 | 1078 | 0.190 |
Why?
| | Renal Insufficiency | 1 | 2023 | 137 | 0.180 |
Why?
| | Diabetic Angiopathies | 4 | 2007 | 246 | 0.180 |
Why?
| | Life Style | 3 | 2012 | 428 | 0.170 |
Why?
| | Male | 25 | 2017 | 55396 | 0.170 |
Why?
| | Female | 25 | 2017 | 59325 | 0.160 |
Why?
| | Self Care | 2 | 2012 | 350 | 0.160 |
Why?
| | Health Literacy | 1 | 2021 | 160 | 0.150 |
Why?
| | Nisoldipine | 3 | 2009 | 6 | 0.150 |
Why?
| | Enalapril | 3 | 2009 | 15 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 486 | 0.150 |
Why?
| | Exercise | 1 | 2008 | 1642 | 0.140 |
Why?
| | Poverty | 3 | 2017 | 440 | 0.140 |
Why?
| | Prospective Studies | 6 | 2012 | 6195 | 0.140 |
Why?
| | Healthy Lifestyle | 1 | 2017 | 30 | 0.140 |
Why?
| | Urban Population | 2 | 2017 | 396 | 0.130 |
Why?
| | Focus Groups | 2 | 2015 | 378 | 0.130 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2008 | 102 | 0.120 |
Why?
| | Educational Status | 1 | 2017 | 408 | 0.120 |
Why?
| | Triglycerides | 1 | 2017 | 467 | 0.120 |
Why?
| | Diabetic Neuropathies | 2 | 2006 | 78 | 0.120 |
Why?
| | Accelerometry | 1 | 2015 | 73 | 0.120 |
Why?
| | Rural Health Services | 1 | 2015 | 92 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2005 | 121 | 0.110 |
Why?
| | Risk Assessment | 4 | 2011 | 2958 | 0.110 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 373 | 0.110 |
Why?
| | Aged, 80 and over | 4 | 2016 | 6306 | 0.110 |
Why?
| | Pilot Projects | 2 | 2015 | 1360 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2008 | 3254 | 0.100 |
Why?
| | Geographic Information Systems | 1 | 2011 | 37 | 0.090 |
Why?
| | Registries | 2 | 2009 | 1764 | 0.090 |
Why?
| | Guideline Adherence | 2 | 2007 | 489 | 0.090 |
Why?
| | Medically Uninsured | 1 | 2012 | 122 | 0.090 |
Why?
| | Algorithms | 2 | 2008 | 1469 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 524 | 0.090 |
Why?
| | Carotid Artery Diseases | 1 | 2011 | 57 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2012 | 1381 | 0.090 |
Why?
| | Time Factors | 7 | 2011 | 6077 | 0.090 |
Why?
| | Myocardial Infarction | 3 | 2006 | 932 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 635 | 0.090 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 1791 | 0.090 |
Why?
| | Fumarates | 1 | 2009 | 10 | 0.080 |
Why?
| | Health Maintenance Organizations | 1 | 2009 | 93 | 0.080 |
Why?
| | Rural Population | 1 | 2012 | 443 | 0.080 |
Why?
| | Comorbidity | 3 | 2009 | 1447 | 0.080 |
Why?
| | Urban Health Services | 1 | 2009 | 60 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 544 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2015 | 756 | 0.080 |
Why?
| | Young Adult | 2 | 2015 | 10444 | 0.080 |
Why?
| | Logistic Models | 3 | 2009 | 1829 | 0.080 |
Why?
| | Risk Management | 1 | 2009 | 89 | 0.080 |
Why?
| | Amides | 1 | 2009 | 87 | 0.080 |
Why?
| | Medical Errors | 1 | 2009 | 86 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2009 | 1080 | 0.080 |
Why?
| | Blood Glucose | 1 | 2017 | 1827 | 0.080 |
Why?
| | Minority Groups | 1 | 2010 | 223 | 0.070 |
Why?
| | Diabetes Complications | 2 | 2009 | 208 | 0.070 |
Why?
| | Disease Management | 1 | 2012 | 556 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2009 | 1422 | 0.070 |
Why?
| | Motivation | 1 | 2012 | 488 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 1 | 2008 | 88 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2012 | 2384 | 0.070 |
Why?
| | Electrocardiography | 2 | 2008 | 561 | 0.070 |
Why?
| | Valsartan | 1 | 2006 | 22 | 0.070 |
Why?
| | Health Status | 1 | 2011 | 716 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2008 | 9049 | 0.070 |
Why?
| | Kidney Function Tests | 1 | 2006 | 140 | 0.070 |
Why?
| | Program Development | 1 | 2008 | 339 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 979 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 349 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2009 | 12521 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 424 | 0.060 |
Why?
| | Exercise Tolerance | 1 | 2006 | 212 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2012 | 799 | 0.060 |
Why?
| | Diabetic Retinopathy | 1 | 2006 | 149 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2007 | 308 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1206 | 0.060 |
Why?
| | Glomerular Filtration Rate | 2 | 2023 | 605 | 0.060 |
Why?
| | Reagent Strips | 1 | 2004 | 4 | 0.060 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2005 | 180 | 0.060 |
Why?
| | Calcium | 1 | 2009 | 1089 | 0.050 |
Why?
| | Kidney | 1 | 2009 | 1182 | 0.050 |
Why?
| | Incidence | 4 | 2011 | 2314 | 0.050 |
Why?
| | Research Design | 1 | 2008 | 919 | 0.050 |
Why?
| | Peripheral Vascular Diseases | 1 | 2003 | 97 | 0.050 |
Why?
| | Heart Ventricles | 1 | 2006 | 723 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 327 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2005 | 666 | 0.050 |
Why?
| | Prognosis | 1 | 2008 | 3315 | 0.040 |
Why?
| | Disease Progression | 1 | 2006 | 2371 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1382 | 0.040 |
Why?
| | Stroke | 2 | 2003 | 1019 | 0.040 |
Why?
| | Odds Ratio | 3 | 2005 | 951 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2010 | 492 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 17800 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1310 | 0.030 |
Why?
| | United States | 3 | 2021 | 12137 | 0.030 |
Why?
| | Hospitals | 2 | 2009 | 581 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3397 | 0.030 |
Why?
| | Heart Failure | 1 | 2004 | 1958 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 4402 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 159 | 0.020 |
Why?
| | Information Dissemination | 1 | 2012 | 185 | 0.020 |
Why?
| | Mexican Americans | 1 | 2010 | 101 | 0.020 |
Why?
| | Medication Errors | 1 | 2009 | 88 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 441 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 571 | 0.020 |
Why?
| | Health Surveys | 1 | 2010 | 441 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 813 | 0.020 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2012 | 505 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2008 | 291 | 0.020 |
Why?
| | Medical Audit | 1 | 2007 | 75 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 233 | 0.020 |
Why?
| | Hospitalization | 2 | 2006 | 1762 | 0.020 |
Why?
| | Public Policy | 1 | 2006 | 61 | 0.020 |
Why?
| | Smoking Prevention | 1 | 2006 | 157 | 0.020 |
Why?
| | Smoke | 1 | 2006 | 123 | 0.020 |
Why?
| | Specific Gravity | 1 | 2004 | 11 | 0.010 |
Why?
| | Exercise Test | 1 | 2006 | 547 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 587 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1638 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1577 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1168 | 0.010 |
Why?
| | Survivors | 1 | 2006 | 412 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 662 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 302 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 2885 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2003 | 113 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2006 | 374 | 0.010 |
Why?
| | Hypolipidemic Agents | 1 | 2003 | 86 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2003 | 160 | 0.010 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 459 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 2003 | 307 | 0.010 |
Why?
| | Internet | 1 | 2005 | 591 | 0.010 |
Why?
| | Patient Discharge | 1 | 2007 | 770 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2005 | 926 | 0.010 |
Why?
| | Mental Disorders | 1 | 2008 | 889 | 0.010 |
Why?
| | Substance-Related Disorders | 1 | 2008 | 942 | 0.010 |
Why?
| | Body Mass Index | 1 | 2006 | 1957 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2003 | 1656 | 0.010 |
Why?
| | Coronary Artery Disease | 1 | 2003 | 611 | 0.010 |
Why?
|
|
Estacio's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|